Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Dec 28, 2016
Green production of cocrystals using a new solvent-free approach by spray congealing
Read more
Scientific Article
/ Dec 28, 2016
Electrophilic reagents for monohalomethylation, their preparation and their uses
Read more
Scientific Article